Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 8Leiomyoma 7Cushing Syndrome 4ACTH Syndrome, Ectopic 4Triple Negative Breast Neoplasms 3Prostatic Neoplasms 3Pituitary Diseases 3Pituitary ACTH Hypersecretion 3Ovarian Neoplasms 2Hirsutism 2Fallopian Tube Neoplasms 2Choristoma 2Carcinoma, Ovarian Epithelial 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms, Male 2Adrenal Cortex Neoplasms 2Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2 1Uterine Hemorrhage 1Sarcoma 1Neoplasms 1Meningioma 1Gulf War Illness 1Endometrial Stromal Tumors 1Endometrial Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Intraductal, Noninfiltrating 1Bulbo-Spinal Atrophy, X-Linked 1Breast Cancer Female 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 99Fluorouracil 90Capecitabine 86Radiotherapy 81Dexamethasone 81Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Drug Therapy 65Leucovorin 64Cetuximab 60Erlotinib Hydrochloride 56atezolizumab 53Sorafenib 53Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Mifepristone × Clear all
NCT00832871 2018-06-29

Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers

New Mexico Cancer Research Alliance

Phase NA Terminated
4 enrolled 4 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡